We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,365 hedge funds and large institutions have $173B invested in Thermo Fisher Scientific in 2023 Q3 according to their latest regulatory filings, with 141 funds opening new positions, 967 increasing their positions, 887 reducing their positions, and 135 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 967 | Existing positions reduced: 887

4% more first-time investments, than exits

New positions opened: 141 | Existing positions closed: 135

0.89% less ownership

Funds ownership: 89.44%88.54% (-0.89%)

1% less funds holding

Funds holding: 2,3882,365 (-23)

2% less call options, than puts

Call options by funds: $1.23B | Put options by funds: $1.25B

3% less capital invested

Capital invested by funds: $178B → $173B (-$4.73B)

1% less funds holding in top 10

Funds holding in top 10: 141139 (-2)

Holders
2,365
Holders Change
-23
Holders Change %
-0.96%
% of All Funds
37.53%
Holding in Top 10
139
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-1.42%
% of All Funds
2.21%
New
141
Increased
967
Reduced
887
Closed
135
Calls
$1.23B
Puts
$1.25B
Net Calls
-$26.6M
Net Calls Change
+$128M
Name Holding Trade Value Shares
Change
Change in
Stake
FAT
651
First American Trust
California
$8.49M -$71.9K -135 -0.8%
CAM
652
Congress Asset Management
Massachusetts
$8.48M +$518K +973 +6%
PNAA
653
Pictet North America Advisors
Switzerland
$8.4M +$2.32M +4,362 +36%
LKIM
654
Lawson Kroeker Investment Management
Nebraska
$8.39M +$13.3K +25 +0.2%
OCAM
655
Onex Canada Asset Management
Ontario, Canada
$8.36M -$717K -1,345 -8%
CCM
656
Cinctive Capital Management
New York
$8.36M +$8.8M +16,510 New
OAM
657
Ostrum Asset Management
France
$8.34M -$421K -790 -5%
TC
658
Tenere Capital
New York
$8.34M -$1.14M -2,132 -11%
RWM
659
RKL Wealth Management
Pennsylvania
$8.33M -$262K -491 -3%
RCM
660
Ravenstone Capital Management
$8.28M -$84.2K -158 -1%
FHA
661
First Horizon Advisors
Tennessee
$8.26M +$200K +376 +2%
AWCI
662
Alpine Woods Capital Investors
New York
$8.24M +$1.59M +2,977 +22%
IUHSA
663
Itau Unibanco Holding S.A.
Brazil
$8.22M +$8.43M +15,814 +3,774%
AIM
664
Achmea Investment Management
Netherlands
$8.2M -$4.61M -8,646 -35%
AWS
665
Atria Wealth Solutions
New York
$8.19M -$87.4K -164 -1%
BPIM
666
Brant Point Investment Management
New York
$8.19M -$112K -211 -1%
FNBOO
667
First National Bank of Omaha
Nebraska
$8.15M -$1.27M -2,379 -13%
MLICM
668
Metropolitan Life Insurance Company (MetLife)
New York
$8.08M -$449K -842 -5%
PVI
669
Pine Valley Investments
New Jersey
$8.03M +$44.8K +84 +0.5%
WMSA
670
Weiss Multi-Strategy Advisers
New York
$7.99M +$555K +1,041 +7%
AAB
671
ABN AMRO Bank
Netherlands
$7.9M -$659K -1,236 -7%
MCM
672
McKinley Capital Management
Alaska
$7.89M -$2.81M -5,280 -25%
PA
673
Perennial Advisors
New York
$7.89M +$15.5K +29 +0.2%
DR
674
Davis Rea
Ontario, Canada
$7.87M +$10.1K +19 +0.1%
FC
675
FORA Capital
Florida
$7.83M +$465K +873 +6%

TMO Hedge Fund Activity: Q3 2023 in Review

2,365 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2023, worth a combined $173B — down 2.7% from $178B a quarter earlier.

Buyers outnumbered sellers: 141 funds opened new TMO positions and 135 closed out — a net gain of 6 holders — while 967 added to existing stakes and 887 trimmed.

The largest buyer was DZ Bank, adding an estimated $755M. The largest seller was Arthur M. Cohen & Associates, cutting an estimated $1.66B.

  • 2,365 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2023, down from 2,388 in Q2 2023.
  • Funds reported $173B of Thermo Fisher Scientific stock for Q3 2023, down 2.7% quarter-over-quarter.
  • 141 funds opened new Thermo Fisher Scientific positions in Q3 2023 and 135 closed out, a net change of +6 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2023 was DZ Bank, an estimated $755M added.
  • The largest Thermo Fisher Scientific seller in Q3 2023 was Arthur M. Cohen & Associates, an estimated $1.66B sold.

Based on aggregated 13F filings for Q3 2023.